Glutathione‐S‐Transferase π Expression in Transitional Cell Carcinoma of the Bladder

D. J. THOMAS, P. J. BIRCH, J. VICKERS, M. ROBINSON, S. CLIFFORD, A. HALL, D. E. NEAL

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Summary Glutathione‐S‐transferase π (GSTπ) is a multifunctional protein that acts as an enzyme, involved in the detoxification of drugs and carcinogens. It has been implicated both in drug resistance and malignant transformation of epithelium. Using an indirect immunohistochemical technique, we have evaluated cytoplasmic and nuclear staining in normal urothelium, 23 superficial bladder tumours and 26 invasive tumours. All 26 invasive tumours had been treated with platinum‐based chemotherapy. Cytoplasmic staining was seen in normal urothelium and all bladder tumours. Nuclear staining was seen in 1 superficial tumour and in 13 invasive tumours. There was no association between nuclear staining and response to chemotherapy. Nuclear staining was seen in 1 area of dysplasia and in 2 of 3 areas of carcinoma in situ. GSTπ expression is not a predictor of response to chemotherapy. Increased intra‐nuclear expression of GSTπ may be associated with progression of transitional cell carcinoma of the bladder.

Original languageEnglish
Pages (from-to)740-743
Number of pages4
JournalBritish Journal of Urology
Volume72
Issue number5
DOIs
StatePublished - Nov 1993
Externally publishedYes

Fingerprint

Dive into the research topics of 'Glutathione‐S‐Transferase π Expression in Transitional Cell Carcinoma of the Bladder'. Together they form a unique fingerprint.

Cite this